Brooks Laboratories Ltd vs Lactose India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Brooks Laboratories Ltd is ₹ 54.77 as of 05 May 15:30 . The P/E Ratio of Brooks Laboratories Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Lactose (India) Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Brooks Laboratories Ltd changed from ₹ 153.53 crore on March 2021 to ₹ 317.37 crore on March 2025 . This represents a CAGR of 15.63% over 5 yearsThe Market Cap of Lactose (India) Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Brooks Laboratories Ltd for the Dec '25 is ₹ 21.89 crore as compare to the Sep '25 revenue of ₹ 29.58 crore. This represent the decline of -26% The revenue of Lactose (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Brooks Laboratories Ltd for the Dec '25 is ₹ 6.05 crore as compare to the Sep '25 ebitda of ₹ 8.65 crore. This represent the decline of -30.06% The ebitda of Lactose (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Brooks Laboratories Ltd changed from ₹ -2.41 crore to ₹ 5.5 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Lactose (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Brooks Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lactose (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Brooks Laboratories Ltd

Brooks Laboratories Limited was incorporated on January 23, 2002.
The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers.
The Company is a pharmaceutical manufacturing company working on contract basis and have its own marketing team to cater the critical care segment.
It offer a variety of dosage from Beta lactam Tablets, Beta lactam Dry Syrup, General Injections, Liquid Injections, Dry Powder Injections, and Eye/Ear Drops, Oncology Products, Hormonal Injections etc. The company's manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes.
At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India.

About Lactose (India) Ltd

Lactose (India) Limited was incorporated on March 1991 as a Public Limited Company in Vadodara district of Gujarat.
Company engages in the manufacturing and trading of pharmaceutical products.
It edible and pharmaceutical grade lactose, as an ingredient used in pharmaceutical products, as well as in dairy, food, confectionery, and beverage industries.
It also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
Further, it engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat.

FAQs for the comparison of Brooks Laboratories Ltd and Lactose (India) Ltd

Which company has a larger market capitalization, Brooks Laboratories Ltd or Lactose (India) Ltd?

Market cap of Brooks Laboratories Ltd is 163 Cr while Market cap of Lactose (India) Ltd is 141 Cr

What are the key factors driving the stock performance of Brooks Laboratories Ltd and Lactose (India) Ltd?

The stock performance of Brooks Laboratories Ltd and Lactose (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brooks Laboratories Ltd and Lactose (India) Ltd?

As of May 5, 2026, the Brooks Laboratories Ltd stock price is INR ₹55.59. On the other hand, Lactose (India) Ltd stock price is INR ₹112.2.

How do dividend payouts of Brooks Laboratories Ltd and Lactose (India) Ltd compare?

To compare the dividend payouts of Brooks Laboratories Ltd and Lactose (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.